Praxis Precision Medicines Quarterly Balance Sheet
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Praxis Precision Medicines financial position
As of Jun 30, 2026, Praxis Precision Medicines reported total assets of $1.39 billion, up 207.0% from a year earlier against total liabilities of $49.1 million. Shareholders' equity stood at $1.34 billion, or 96.5% of assets. The company held $474.8 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 15.73, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Praxis Precision Medicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 474.76M | 536.33M | 357.33M | 149.53M | 157.41M | 165.57M | 215.37M | 168.65M | 145.14M | 151.98M | 81.30M | 101.08M |
| Short-Term Investments | 283.79M | 250.53M | 242.00M | 117.63M | 143.86M | 162.42M | 177.19M | 188.39M | 206.74M | 55.44M | 0 | — |
| Total Current Assets | 771.90M | 797.77M | 610.91M | 273.84M | 306.58M | 333.57M | 404.37M | 360.05M | 356.72M | 211.80M | 84.88M | 103.33M |
| Property, Plant & Equipment | 492.00K | 170.00K | 147.00K | 174.00K | 258.00K | 247.00K | 230.00K | 277.00K | 369.00K | 476.00K | 588.00K | 700.00K |
| Intangible Assets | 773.00K | — | 0 | — | — | — | — | — | — | — | — | — |
| Long-Term Investments | 615.29M | 660.94M | 326.76M | 122.01M | 145.37M | 144.03M | 76.96M | 54.14M | 81.95M | 35.87M | 0 | — |
| Total Assets | 1.39B | 1.46B | 937.91M | 396.39M | 452.83M | 478.74M | 483.11M | 416.26M | 441.06M | 250.41M | 87.95M | 106.72M |
| Accounts Payable | 23.39M | 31.16M | 24.63M | 30.82M | 28.83M | 22.91M | 12.53M | 15.01M | 8.20M | 9.40M | 5.82M | 7.17M |
| Total Current Liabilities | 49.06M | 50.24M | 59.77M | 52.88M | 48.61M | 39.52M | 37.55M | 32.86M | 20.62M | 18.79M | 15.75M | 16.79M |
| Total Liabilities | 49.06M | 50.24M | 59.77M | 52.88M | 48.61M | 39.52M | 37.66M | 33.59M | 21.96M | 20.73M | 18.28M | 19.97M |
| Shareholders' Equity | 1.34B | 1.41B | 878.14M | 343.50M | 404.22M | 439.21M | 445.45M | 382.67M | 419.10M | 229.68M | 69.67M | 86.76M |
| Retained Earnings | -1.32B | -1.23B | -1.14B | -1.05B | -977.16M | -906.04M | -836.74M | -778.06M | -726.15M | -693.47M | -653.92M | -627.04M |
| Net Cash (Debt) | 758.55M | 786.87M | 599.33M | 267.16M | 301.27M | 327.99M | 392.57M | 357.03M | 351.88M | 207.42M | 81.30M | 101.08M |
| Shares Outstanding | 27.92M | 27.86M | 25.20M | 21.17M | 21.04M | 20.34M | 19.42M | 17.79M | 17.76M | 13.26M | 8.79M | 128.55M |
This table shows 12 quarterly periods of Praxis Precision Medicines's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow PRAX's reporting calendar. What is a balance sheet?